Hip Replacement Market Analysis

Hip Replacement Market Analysis

The primary hip replacement devices segment held more than USD 5.49 billion in 2022. The benefits offered by primary hip replacement procedures include improved function, pain relief, and advanced quality of life among others resulting in augmenting the segment revenue in foreseeable future. Additionally, manufacturers in the market offer a comprehensive portfolio of technologically advanced hip products coupled with a focus on specific requirements of individual patients. The notable growth rate of the segment is owing to developments in hip joint replacement surgical methods that reduce the risk of chronic health conditions and allow the removal of the diseased bone & cartilage. The surging adoption of hip replacement devices is due to the high success rate of primary hip replacement surgery.
 

Based on material, the hip replacement market is classified into metal-on-plastic, ceramic-on-plastic, ceramic-on-ceramic, and others. The metal-on-plastic segment accounted for more than USD 4.22 billion in 2022. The significant revenue share is owing to the advantages metal-on-plastic devices offer that includes durability, precise outcome, affordable alternative, etc. Metal-on-plastic hip replacement devices are a better alternative for less active patients and are the most regularly used hip replacement implants. Furthermore, several other benefits such as technological advancements, fewer complications, and lesser wear particles are increasing its adoption. The most used metal and plastic include stainless steel & titanium and polyethylene, respectively. It is the widely used artificial hip component material chosen by surgeons owing to its advantages. For instance, as per the recent research article, metal-on-plastic hip implant may advance hip resurfacing results and offer good long-term outcomes in aged patients.
 

Hip replacement market from cemented fixation segment is anticipated to reach over USD  762 million by 2032. This steady growth rate is due to benefits such as high survival rate, forms an interlocking fit between implant & bone, and allows the bone to grow onto the implant over time. For instance, the survival rate of cemented fixation used at 10 years is around 96% in patients aged over 75 years. Cemented fixation uses fast-drying bone cement to attach the patient's natural bone and the prosthetic joint component. A small amount of antibiotic material can be added to the bone as the cement dries within 10 minutes of application thus, helps to reduce the risk of post-surgical infection.
 

Based on inserts, the hip replacement market is segmented as cross-linked polyethylene inserts, antioxidant polyethylene inserts, and non-antioxidant polyethylene inserts. The cross-linked polyethylene inserts segment is anticipated to reach over USD 3.43 billion by 2032. The advantages of cross-linked polyethylene include reduced osteolysis, offers excellent clinical outcomes, and implant survivorship among others resulting in augmenting the segment revenue in foreseeable future. These inserts are developed precisely to decrease polyethylene wear and subsequent wear debris-induced osteolysis. For instance, clinical studies have demonstrated that cross-linked polyethylene inserts have a high success rate in primary hip arthroplasty.
 

Moreover, in hip replacement procedures, this insert is comparatively insensitive to femoral head size, allows the surgeon to use large femoral heads to strengthen hip stability and decrease post-operative complications. According to the article published by the National Center for Biotechnology Information (NCBI), cross-linked polyethylene inserts have been widely adopted and are highly effective 15 years after the surgery in a young & active individual.  Hence, owing to these attributes the industry is anticipated to witness a lucrative growth in the coming years.